GHK-Cu
What the skin studies show — and what the injectable claims leave out
GHK-Cu is a real, well-studied molecule with genuine topical skin and wound research behind it. But the evidence depends entirely on the outcome and the route — strong for topical skin support, thin for injectable anti-aging, and mostly absent for systemic use. Most online hype collapses that distinction.
Route Integrity Warning
Evidence cannot be transferred across delivery routes. Nearly all of GHK-Cu's human evidence concerns topical application. It should not be read as evidence for injectable or systemic use, which has little to no rigorous human study and introduces different risks — including copper exposure. Vendor pages routinely blur this line; we keep it sharp.
What it is
GHK-Cu (glycyl-L-histidyl-L-lysine complexed with copper) is a naturally occurring human tripeptide, first isolated from blood plasma in 1973. Plasma levels fall with age — from roughly 200 ng/mL around age 20 to about 80 ng/mL by 60 — which is part of why it became a research target for skin, hair, and wound healing.
In cosmetics it's regulated as an ingredient called Copper Tripeptide-1, not as an approved drug. It is not FDA-approved for any medical indication; medical or injectable uses are off-label or investigational.
Evidence by outcome
A single score for "GHK-Cu" would be misleading — the evidence is strong for some uses and nearly absent for others. Here is how it actually breaks down, by outcome and by route.
The delivery problem
The catch that most claims ignore: GHK-Cu barely penetrates intact skin. A 2015 permeation study found near-zero absorption through an unbroken skin barrier — the molecule reaches the dermis in meaningful amounts only when the barrier is bypassed (for example, by microneedling). Unprotected GHK also degrades within hours of application, which is why formulation and encapsulation matter as much as concentration.
This is exactly why route and formulation can't be waved away: a benefit shown for one delivery method doesn't automatically hold for a cream on intact skin — or for an injection.
The Claim Gap
Our signature measure: the distance between how confidently GHK-Cu is promoted online and how confidently the evidence supports it. It varies sharply by claim.
Injectable anti-aging & longevity
"Injectable copper peptide that reaches every tissue for full-body anti-aging and regeneration."
No rigorous controlled human trials support injectable cosmetic or systemic anti-aging benefit. The rationale is extrapolated from topical and preclinical work, and systemic copper carries its own safety considerations.
Topical skin support
"Reverses aging and dramatically rebuilds collagen from a topical serum."
Genuine collagen-stimulating activity and small clinical support for skin quality — but effects are modest and constrained by how little penetrates intact skin.
Safety, honestly
Topical: generally well tolerated. Pooled data across recent studies report mostly mild effects — transient redness or itching in a small percentage — with no sign of systemic copper overload from cosmetic use.
Injectable / systemic: a different and less-characterized picture. Copper is an essential trace element, but excess copper can be harmful, and long-term safety data for sustained systemic GHK-Cu in humans does not meaningfully exist. People with copper-metabolism disorders such as Wilson's disease should be especially cautious with any copper-containing preparation. This is reported for transparency and education — not as guidance to use anything.
Key citations
- 01Pickart L, Margolina A. — Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci, 2018. PMC6073405
- 02Park et al. — GHK-Cu serum vs. minoxidil in androgenetic alopecia, RCT (n=50), 2022.
- 03Li et al. — Skin permeation of GHK-Cu; near-zero flux through intact skin. Pharmaceutical Research, 2015.
These are three of 42 indexed papers. The complete outcome-by-outcome evidence ledger is in the deep-dive below.
The Deep-Dive
Every outcome, every route, fully mapped
The complete 42-paper ledger tagged by outcome, route, and formulation — plus the full Claim Gap breakdown, study-by-study cards, and the safety-signal record.